Medicis Pharmaceutical Corporation (MRX)
Medicis Pharmaceutical Corporation Revenues: 201.74M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
MRX Revenues Rankings
| Overall | 60th percentile | 1759 of 4432 |
| Sector | 75th percentile | 115 of 470 in Healthcare |
| Industry | 66th percentile | 4 of 12 in Drugs - Generic |
MRX Revenues Range, Past 5 Years
| Minimum | 99.82M | Mar 2009 |
| Maximum | 201.74M | Mar 2012 |
| Average | 153.47M |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity.
Learn More
You may also be interested in these MRX related companies
MRX News
$MRX Mentioned more than normal on StockTwits - Currently at 8 x average daily social activity
about 5 days ago by TradeIdeasQuant
about 5 days ago by TradeIdeasQuant
Barclays on U.S. Specialty Pharmaceuticals: Model Updates on FRX, MRX, WCRX & PCRX
May 25, 12:32PM Street Insider
May 25, 12:32PM Street Insider
Goldman Calls Medicis (MRX) 'One of the Most Likely M&A Targets' in Specialty Pharma Space
May 25, 11:38AM Street Insider
May 25, 11:38AM Street Insider
Cantor Fitzgerald Maintains a 'Hold' on Medicis (MRX); Looking For The Accretive Transaction
May 14, 9:53AM Street Insider
May 14, 9:53AM Street Insider
Medicis to Present at Bank of America Merrill Lynch 2012 Health Care Conference
May 14, 8:00AM GlobeNewswire
May 14, 8:00AM GlobeNewswire
Auriga Reiterates a 'Buy' on Medicis (MRX); Q1 Beat Underscores Execution
May 10, 1:46PM Street Insider
May 10, 1:46PM Street Insider
Listen to $MRX First Quarter 2012 Medicis Earnings Conference Call - live at 05:15 PM, ondemand after - http://stks.co/3jQK
about 22 days ago by earningscast
about 22 days ago by earningscast
$MRX made 7k off this stock and peeved because i couldnt raise my sell price quick enough!
about 22 days ago by strategymizer
about 22 days ago by strategymizer
RT @TheEquitiesRoom Notables trading down to 50d MA: $ADS $MRX $VFC $CSTR $CHMT $WOOF $KLIC
about 24 days ago by HuberMarketNote
about 24 days ago by HuberMarketNote
Needham & Company Reiterates a 'Buy' on Solta Medical (SLTM); Good Quarter
May 02, 9:20AM Street Insider
May 02, 9:20AM Street Insider
Cantor Fitzgerald Maintains a 'Hold' on Medicis (MRX); Adjusting Numbers
Apr 19, 8:45AM Street Insider
Apr 19, 8:45AM Street Insider
$MRX setting up for the next leg higher. http://chart.ly/ltstspt
about 42 days ago by AffluenzaVirus
about 42 days ago by AffluenzaVirus
$MRX filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3Klz
about 47 days ago by MarketBrief
about 47 days ago by MarketBrief
$MRX filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3IZ5
about 49 days ago by MarketBrief
about 49 days ago by MarketBrief
$MRX filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3HIW
about 51 days ago by MarketBrief
about 51 days ago by MarketBrief
$MRX filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3GLH
about 52 days ago by MarketBrief
about 52 days ago by MarketBrief
$MRX filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3FPR
about 54 days ago by MarketBrief
about 54 days ago by MarketBrief
Deutsche Bank Maintains a 'Buy' on Medicis (MRX) After In-Depth Meeting with Management
Apr 05, 9:56AM Street Insider
Apr 05, 9:56AM Street Insider
$MRX filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3EQY
about 55 days ago by MarketBrief
about 55 days ago by MarketBrief
$MRX filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3DKL
about 56 days ago by MarketBrief
about 56 days ago by MarketBrief
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| MRX | 36.73 | -0.35 | -0.94% | 2.185B |
| MRVL | 12.74 | -0.31 | -2.38% | 7.647B |
| MRO | 24.86 | -0.66 | -2.59% | 17.97B |
| MRNAD | 0.7203 | -0.09 | -11.07% | |
| MRNA | 0.7389 | +0.02 | +2.58% | 5.842M |
| MRLN | 13.98 | -0.39 | -2.71% | 182.64M |
| MRK | 37.41 | -0.18 | -0.48% | 114.42B |
| MRH | 20.44 | -0.10 | -0.49% | 1.219B |
| MRGE | 2.40 | -0.08 | -3.23% | 225.70M |
| MRF | 7.84 | -0.06 | -0.76% |